Jane Street
IBBQ icon

Jane Street’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Jane Street’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,396
Closed -$939K – 12242
2026
Q1 		$939K Buy
+32,396
New +$943K ﹤0.01% 6649

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Jane Street's IBBQ Position: Q2 2026 in Review

Jane Street sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q2 2026, closing a stake of 32,396 shares — an estimated $939K sold.

Jane Street first reported a position in IBBQ in Q1 2026 and held it in 1 quarter. The position peaked at $939K in Q1 2026. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Jane Street reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 32,396 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $939K.
  • Jane Street first reported a position in Invesco NASDAQ Biotechnology ETF in Q1 2026 and held it in 1 quarter.
  • Jane Street's Invesco NASDAQ Biotechnology ETF position peaked at $939K in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.